Superoxide Dismutase–Peptide Veterinary Composition for Animal Anxiety

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for anxiety and fear-related disorders in companion animals, such as dogs and cats, are limited by slow action times, contraindications, and undesirable side effects, and existing supplements lack consistent anxiolytic effects, particularly in representative canine populations.

Innovation Solution

A veterinary composition comprising superoxide dismutase (SOD) and a protein hydrolysate rich in bioassimilable peptides, administered orally, to prevent, regulate, and treat fear, anxiety, and associated behavior disorders, with a peptide fraction less than 1% having a molecular weight greater than 10,000 Da, and a ratio of SOD to protein hydrolysate between 0.01:100 and 100:1.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If psychotropic drugs like clomipramine are used to treat anxiety in dogs, then anxiolytic effect is achieved, but action time is slow and side effects occur

Engineering Contradiction:
Improveanxiolytic effectVSAvoidaction time
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent changes the chemical composition parameters by using natural compounds (alpha-casozepine, L-theanine, tryptophan) instead of traditional psychotropics, and optimizes their ratios to achieve faster action with fewer side effects

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces peptide hydrolysates as intermediary substances that facilitate the action of active compounds, enhancing absorption and effectiveness while reducing the need for high doses of individual ingredients

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If peptide hydrolysate is used as anxiolytic supplement, then effectiveness is improved, but molecular weight distribution affects bioavailability

Engineering Contradiction:
Improveanxiolytic effectivenessVSAvoidbioassimilable peptide concentration
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent segments proteins into peptides of specific molecular weights (predominantly <3000 Da) to optimize bioavailability and absorption while maintaining the therapeutic benefits of the peptide structure

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates different peptide fractions with specific molecular weight distributions tailored for different absorption rates and biological activities, optimizing the overall anxiolytic effect

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively reduces anxiety and fear responses in companion animals, improves learning processes, and promotes positive interactions with humans, without contraindications, and is suitable for multiple species, including dogs and cats.

Implementation Method 1

superoxide dismutase (SOD)... This melon juice concentrate rich in superoxide dismutase has been validated for its antioxidant and anti-inflammatory properties

Methodology Applied
Scientific EffectSuperoxide dismutase catalysis: Catalysis

Implementation Method 2

at least one hydrolysate of proteins rich in bioassimilable peptides

Methodology Applied
Scientific EffectProtein hydrolysis: Hydrolysis

Data Source

PatentUS20250213660A1Veterinary Composition Comprising Superoxide Dismutase and at Least One Hydrolysate of Proteins Rich in Bioassimilable Peptides
Publication Date: 2025.07.03 MP LAB
  • US20250213660A1 patent drawing

AI summary

A veterinary composition comprising, in effective amounts, superoxide dismutase and at least one protein hydrolysate rich in bioassimilable peptides.